Trial Profile
Effect of CTAP101 Capsules on Serum Calcium, Plasma Intact Parathyroid Hormone and Vitamin D Metabolites in Patients With Advanced Breast or Prostate Carcinomas With Metastases to Bone and Receiving Ongoing Therapy With Denosumab or Zoledronic Acid
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Calcifediol (Primary)
- Indications Bone cancer; Breast cancer; Hyperparathyroidism; Prostate cancer
- Focus Adverse reactions; Pharmacodynamics
- Sponsors OPKO Health
- 25 Sep 2019 Status changed from active, no longer recruiting to completed.
- 20 Sep 2017 Status changed from recruiting to active, no longer recruiting.
- 11 Apr 2017 Planned End Date changed from 1 Feb 2017 to 1 Dec 2018.